Disease Info Card

Malignant Childhood Neoplasm

Information about Malignant Childhood Neoplasm: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Malignant Childhood Neoplasm

Most recent studies have shown that Malignant Childhood Neoplasm shares some biological mechanisms with acute-lymphocytic-leukemia, bone-neoplasms, brain-neoplasms, central-nervous-system-neoplasms, hodgkin-disease, kidney-neoplasm, leukemia, lymphoma, lymphoma-non-hodgkin, malignant-neoplasms, malignant-paraganglionic-neoplasm, neoplasms, neoplasms-radiation-induced, neoplasms-second-primary, nephroblastoma, nervousness, neuroblastoma, retinoblastoma, rhabdomyosarcoma, sarcoma.

Among the many pathways, these few ones have gauged particular interests from scientists studying Malignant Childhood Neoplasm, and have been seen in publications frequently: Aging, Angiogenesis, Cell Cycle, Cell Death, Cell Growth, Cell Proliferation, Cognition, Dna Repair, Drug Resistance, Fertilization, Immune Response, Localization, Menarche, Menopause, Methylation, Mismatch Repair, Pathogenesis, Secretion, Spermatogenesis, Translation

Quite a number of genes have been found to play important roles in Malignant Childhood Neoplasm, such as BRD2, CCS, EPO, FOXO1, GGH, GH1, MYCN, NDUFB6, NME1, RB1, SMARCB1, SMN1, SNRPN, STMN1, TP53, VEGFA. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.